Skip to content

Clinical trials

Latent Tuberculosis trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Latent Tuberculosis Country / region: South Korea Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20091
20101
20122
20151
20161
20172
20181
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status6
Completed5
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hanyang University3
Asan Medical Center2
Seoul National University Hospital2
Inje University1
McGill University1
National Institute of Allergy and Infectious Diseases (NIAID)1
Samsung Medical Center1
Yonsei University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Latent Tuberculosis12
Tuberculosis7
Tuberculosis, Pulmonary2
Arthritis, Rheumatoid1
Drug-Related Side Effects and Adverse Reactions1
Mycobacterium Infections, Nontuberculous1
Rheumatic Diseases1
Spondylitis, Ankylosing1
Tuberculosis Disease1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.